AUTOTAXIN, [4-(trifluoromethoxy)phenyl]methyl (3aS,6aS)-2-(1H-benzotriazole-5-carbonyl)-1,3,3a,4,6,… | | monomer | 51-887 | 1×NAG; 1×YVS; 1×ZN; 2×CA; 4×CL; 1×NA; |
Assess |
AUTOTAXIN, (3,5-dichlorophenyl)methyl (3aS,8aR)-2-(1H-benzotriazole-5-carbonyl)-1,3,3a,4,5,7,8,8a-o… | | monomer | 51-886 | 1×NAG; 1×YV1; 3×ACT; 2×PG4; 2×ZN; 3×CA; 1×CL; 1×NA; |
Assess |
AUTOTAXIN, 4-[3-Oxo-3-(2-oxo-2,3-dihydro-benzooxazol-6-yl)-propyl]-piperazine-1-carboxylic acid 3,5… | | monomer | 51-886 | 1×NAG; 2×CA; 1×K; 3×ACT; 1×6ZO; 1×ZN; 1×NA; |
Assess |
Crystal structure of rat autotaxin and compound MEY-002 | | monomer | 52-884 | 1×NAG; 2×ZN; 9×IOD; 6×SCN; 1×5JK; 1×TIJ; 1×P6G; 2×GOL; 1×CA; |
Assess |
Crystal Structure of Autotaxin and Compound 1 | | monomer | 52-884 | 1×NAG; 1×NAG; 1×6ZM; 3×ZN; 1×CL; |
Assess |
Crystal Structure of Autotaxin and Compound 1 | | monomer | 52-884 | 1×NAG; 1×NAG; 1×6ZN; 1×CL; 3×ZN; |
Assess |
Crystal Structure of Autotaxin and Compound PF-8380 | | monomer | 53-884 | 1×NAG; 2×ZN; 1×CA; 1×6ZO; 1×EPE; 1×CL; |
Assess |
Crystal structure of Autotaxin (ENPP2) with 7-alpha-hydroxycholesterol | | monomer | 56-885 | 1×NAG; 2×ZN; 1×5JK; 1×CA; 10×IOD; 11×SCN; 2×NA; 7×GOL; |
Assess |
Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA) and lysophosphatidic … | | monomer | 56-885 | 1×NAG; 2×ZN; 1×CA; 1×NKP; 1×5D5; 2×NA; 13×IOD; 2×SCN; 2×GOL; |
Assess |
Autotaxin in complex with orthosteric site-binder CpdA | | monomer | 56-885 | 1×NAG; 1×NAG; 2×ZN; 1×5JK; 1×CA; 17×IOD; 6×SCN; 2×NA; 9×GOL; 1×IA0; |
Assess |
Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | | monomer | 55-884 | 1×NAG; 12×IOD; 2×ZN; 1×CA; 1×7CF; 2×NA; 10×SCN; 7×GOL; 1×NKP; |
Assess |
Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modu… | | monomer | 56-885 | 1×NAG; 1×MAN; 2×ZN; 1×CA; 4×IOD; 8×SCN; 2×NA; 4×GOL; 1×I8K; |
Assess |
Autotaxin in complex with hybrid compound ziritaxestat (GLPG1690) | | monomer | 56-885 | 1×BMA; 2×NAG; 2×ZN; 1×CA; 10×IOD; 9×SCN; 1×NA; 6×GOL; 1×7NB; |
Assess |
Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | | monomer | 56-884 | 1×NAG; 2×ZN; 14×IOD; 1×CA; 2×NA; 1×5JK; 1×7CR; 17×SCN; 5×GOL; |
Assess |
Crystal structure of Autotaxin (ENPP2) with tauroursodeoxycholic acid (TUDCA) | | monomer | 56-884 | 1×NAG; 2×ZN; 1×CA; 14×IOD; 1×PO4; 2×NA; 1×5D5; 2×SCN; 6×GOL; |
Assess |
Crystal structure of autotaxin (ENPP2) re-refined | | monomer | 56-884 | 1×NAG; 1×5JK; 4×SCN; 2×ZN; 1×PO4; 1×CA; 24×IOD; 2×NA; 1×GOL; |
Assess |
Crystal structure of Autotaxin (ENPP2) | | monomer | 56-884 | 1×NAG; 4×SCN; 2×ZN; 1×CA; 1×PO4; 28×IOD; |
Assess |
Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | | monomer | 56-884 | 1×NAG; 1×CA; 2×ZN; 13×IOD; 1×7CW; 1×NA; 11×SCN; 5×GOL; |
Assess |
Crystal structure of Autotaxin (ENPP2) with 18F-labeled positron emission tomography ligand | | monomer | 56-884 | 1×NAG; 1×NAG; 3×SCN; 2×ZN; 1×CA; 5×IOD; 1×4I0; |
Assess |
Crystal structure of autotaxin with orthovanadate bound as a trigonal bipyramidal intermediate anal… | | monomer | 56-884 | 1×NAG; 1×5JK; 2×ZN; 1×CA; 6×IOD; 2×NA; |
Assess |
Structure of Autotaxin (ENPP2) with LM350 | | monomer | 56-884 | 1×NAG; 2×ZN; 1×CA; 10×IOD; 1×72P; 1×NA; |
Assess |
Structure-based evolution of a hybrid steroid series of Autotaxin inhibitors | | monomer | 56-884 | 1×NAG; 9×IOD; 2×ZN; 1×CA; 1×7C8; 1×NA; 4×SCN; 3×GOL; |
Assess |
Crystal structure of rat autotaxin and compound MEY-003 | | monomer | 56-884 | 1×NAG; 1×T8R; 1×5JK; 2×ZN; 4×IOD; 2×CA; |
Assess |
Crystal structure of Autotaxin and 9(R)-delta6a,10a-THC | | monomer | 56-883 | 1×NAG; 1×5JK; 2×ZN; 1×5K9; 2×SCN; 1×CA; 2×GOL; 12×IOD; |
Assess |
Crystal structure of Autotaxin and tetrahydrocannabinol | | monomer | 56-883 | 1×NAG; 2×ZN; 1×TCI; 1×5JK; 19×IOD; 2×SCN; 8×GOL; 1×PO4; 2×CA; 1×NA; |
Assess |
Crystal structure of Autotaxin (ENPP2) in complex with the HA155 boronic acid inhibitor | | monomer | 56-883 | 1×NAG; 1×SWH; 2×ZN; 1×CA; 5×IOD; |
Assess |